Development and Evaluation of Bilastine-Loaded Nanoemulgel for Enhanced Topical Delivery in Urticaria and Pruritus
International Journal of Drug Delivery Technology · 16.07.2026 · 16 (65s)
DOI: 10.25258/ijddt.16.65s.90 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 16.07.2026. Verfasst von Prathamesh Mali und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Urticaria and pruritus are common dermatological disorders characterized by itching, erythema, inflammation, and wheal formation resulting from histamine-mediated immune responses. Bilastine, a second-generation antihistamine, is widely used for their management; however, oral administration may not provide adequate localized drug concentration at the affected skin site.
Objective
The present study aimed to formulate and evaluate a bilastine-loaded nanoemulgel for enhanced topical delivery in the treatment of urticaria and pruritus. Materials and Methods: Bilastine nanoemulsions were developed using oleic acid as the oil phase, Tween 80 as surfactant, and propylene glycol as co-surfactant. Solubility screening and pseudo-ternary phase diagram studies were performed to optimize formulation composition. Nanoemulsions were characterized for particle size, polydispersity index (PDI), zeta potential, entrapment efficiency, and thermodynamic stability. The optimized nanoemulsion was incorporated into a Carbopol-based gel system and evaluated for pH, viscosity, spreadability, drug content, and in vitro drug release.
Results
The optimized nanoemulsion formulation demonstrated nanosized droplets with narrow size distribution and acceptable zeta potential. Incorporation into the gel base produced a homogeneous and stable nanoemulgel with satisfactory physicochemical characteristics. The optimized nanoemulgel exhibited drug content of 99.35 ± 0.38% and achieved 94.60% cumulative drug release at 12 h, which was significantly higher than that of the conventional gel formulation. Stability studies indicated no significant changes in formulation characteristics during storage.
Conclusion
The developed bilastine nanoemulgel demonstrated improved drug release, satisfactory physicochemical properties, and good stability. The formulation represents a promising topical delivery system for the management of urticaria and pruritus and may provide enhanced therapeutic efficacy with reduced systemic exposure
Zitieren
APA
Mali, P., Bhosale, A., Kakade, S., & Shangrapawar, T. (2026). Development and Evaluation of Bilastine-Loaded Nanoemulgel for Enhanced Topical Delivery in Urticaria and Pruritus. International Journal of Drug Delivery Technology, 16(65s). https://doi.org/10.25258/ijddt.16.65s.90
Vancouver
Mali P, Bhosale A, Kakade S, Shangrapawar T. Development and Evaluation of Bilastine-Loaded Nanoemulgel for Enhanced Topical Delivery in Urticaria and Pruritus. International Journal of Drug Delivery Technology. 2026;16(65s). doi:10.25258/ijddt.16.65s.90
BibTeX
@article{Mali2026,
author = {Mali, Prathamesh and Bhosale, Ashok and Kakade, Sujit and Shangrapawar, Trusha},
title = {Development and Evaluation of Bilastine-Loaded Nanoemulgel for Enhanced Topical Delivery in Urticaria and Pruritus},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {65s},
doi = {10.25258/ijddt.16.65s.90}
}
EUVIMED